Left Menu
Development News Edition

Mr. Binish Chudgar awarded prestigious Ernst & Young 'Entrepreneur of the Year 2018

Mr. Binish Chudgar awarded prestigious Ernst & Young 'Entrepreneur of the Year 2018

Mr Binish Chudgar, Vice Chairman & Managing Director of Intas Pharmaceuticals Ltd., was awarded the prestigious Ernst & Young 'Entrepreneur of the Year 2018' Award in the Life Sciences & Healthcare category. The gala ceremony was held in Jio Garden, Mumbai, India on 12th February 2019 from 6 pm onwards.

EY Entrepreneur of the Year is the world's most prestigious business award for entrepreneurs. As the first and only truly global award of its kind, EY Entrepreneur Of The Year™ celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in 60 countries.

Mr Binish Chudgar has bestowed the award for his multifaceted entrepreneurial ingenuity. His relentless pursuit of excellence through product innovations, strategic acquisitions, consistent growth, strong marketing models and organisational sustainability were the key factors behind his victory.

A second generation entrepreneur, Binish Chudgar is the Vice Chairman and Managing Director of Intas Pharmaceuticals, who first held the reins of the company in the early 1990s, leading strategic growth and finance. Under his leadership, the company has seen exponential growth from <US$1 million to over US$1.7 billion (as of March 2018). Over the years, Mr Chudgar has worked towards expanding the company's footprint in new product segments as well as markets. He also spearheaded the company's biologics strategy, making it the first Indian company to launch a biosimilar in the highly regulated markets of the EU, the US and Japan. Today, Intas is the largest privately-held pharmaceutical organisation in the country.

On receiving the award, Mr Chudgar said that this was an achievement for the entire pharmaceutical industry and invited them to join hands and move forward with dedication and determination. He also expressed his concern about health issues ailing the country and pledged to overcome them. Finally, he dedicated the award to Team Intas, who he said are the backbone of the company.

About Intas

Intas is a leading, vertically integrated global pharmaceutical company from India, having end-to-end capabilities of formulation development, manufacturing and marketing along with backward integration of APIs. Intas' success and incessant growth focus lies in its clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, biotechnology and global operations over the past three decades. Currently ranked 10th in the domestic market, Intas has been growing at ~27% CAGR over the last 5 years with an even stronger profit growth

Intas is also present in more than 85 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central and Latin America, Africa, Australia, New Zealand, Asia-Pacific as well as CIS and MENA countries.

(With inputs from agencies.)

Download The Devdiscourse News App for Latest News.



Future of Food: Technology fostering the road to global food security

Technological innovation can help address most of the pressing issues facing the world today including food security by enhancing productivity, improving financial services, managing resources, addressing environmental concerns, etc....

Conspiracy theories on COVID 19: Legislators, Scientists, and Journalists all joined the Caravan

Conspiracy theories are not new for virus epidemics. There have been conspiracy theories on HIV-AIDS, Polio Vaccines, Ebola Virus, and several other diseases as well. However, what makes the 2019 Novel Coronavirus different from others is ...

Now it’s a war, Uganda deploys army to combat locust swarms

Its for the first time after 1986, the locust swarms have attacked Uganda twice in a season. With the increasing number of countries of Africa under attack by locust swarms, the problem seems to have taken a regional paradigm. Its very diff...

Top 10 Fake News, Myths and Realities on 2019 Novel Coronavirus COVID 19

With nearly 1500 deaths by January 14 and around 65,000 infections in China, the Novel Coronavirus 2019 has become one of the worst health epidemics of the 21st Century. However, 8,573 people have been cured but the&#160;rumor mongers are a...


Latest News

Jordan Peele has no intention of doing 'Get Out' sequel

Hollywood producer Jason Blum has said that filmmaker Jordan Peele has no plans to make a sequel to his 2017 horror blockbuster Get Out. The film, starring Daniel Kaluuya, Allison Williams, Bradley Whitford, Caleb Landry Jones and Catherine...

India looks forward to welcoming US President Donald Trump; honour that he will be with us tomorrow, says PM Modi

India looks forward to welcoming US President Donald Trump honour that he will be with us tomorrow, says PM Modi....

Will preside over West Bengal State University convocation as Chancellor Convocation: Dhankhar

After being prevented from attending the annual convocation of two top state universities, West Bengal Governor Jagdeep Dhankhar on Sunday said he would be presiding over the graduation ceremony at West Bengal State University WBSU. Dhankha...

Market to remain volatile ahead of F&O expiry; investors eye Trump visit

Domestic market is expected to remain volatile ahead of derivatives expiry as investors await fresh cues from US President Donald Trumps visit next week, according to analysts. Market participants will also be eyeing GDP estimates and infra...

Give Feedback